Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Delcath Systems Inc (DCTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,475
  • Shares Outstanding, K 900
  • Annual Sales, $ 2,720 K
  • Annual Income, $ -45,120 K
  • 36-Month Beta -0.51
  • Price/Sales 0.92
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -12,234.78
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/08/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.5400 +8.27%
on 06/21/18
3.4800 -20.98%
on 06/05/18
-0.7400 (-21.20%)
since 05/21/18
3-Month
1.2200 +125.41%
on 05/03/18
6.4400 -57.30%
on 05/07/18
-3.2500 (-54.17%)
since 03/21/18
52-Week
1.2200 +125.41%
on 05/03/18
45,500.0000 -99.99%
on 06/27/17
-47,247.2500 (-99.99%)
since 06/21/17

Most Recent Stories

More News
Delcath Systems to Present at the 8th Annual LD Micro Invitational

Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that it will be presenting at the 8 Annual LD Micro...

DCTH : 2.7500 (unch)
DCTHD : 3.0000 (unch)
Delcath Sponsors Looking For A Cure Ocular Melanoma Charity Event

Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, is proud to sponsor A Cure In Sight and its first annual Looking...

DCTH : 2.7500 (unch)
DCTHD : 3.0000 (unch)
Delcath's CHEMOSAT Included in German Treatment Guidelines for Melanoma Liver Metastases

Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the German Guidelines Program in Oncology (GGPO)...

DCTH : 2.7500 (unch)
DCTHD : 3.0000 (unch)
Delcath's PHP Therapy Featured in Video Learning Session at the European Conference of Interventional Oncology

Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Company's PHP Therapy was featured in a Video...

DCTH : 2.7500 (unch)
DCTHD : 3.0000 (unch)
Delcath Announces First Quarter 2018 Financial Results

Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces financial results for the quarter ended March 31, 2018....

DCTH : 2.7500 (unch)
DCTHD : 3.0000 (unch)
Delcath Systems, Technology Overview, Product Developments and FYE 2017 Review

NEW YORK, NY / ACCESSWIRE / May 8, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report...

DCTH : 2.7500 (unch)
DCTHD : 3.0000 (unch)
Delcath Announces Initiation of Registrational Trial of Melphalan/HDS in Intrahepatic Cholangiocarcinoma

Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Company has initiated its pivotal trial of Melphalan...

DCTH : 2.7500 (unch)
DCTHD : 3.0000 (unch)
Delcath to Present at the RHK Capital 2018 Disruptive Growth and Healthcare Conference

Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces that Jennifer K. Simpson, Ph.D., MSN, CRNP, President...

DCTH : 2.7500 (unch)
DCTHD : 3.0000 (unch)
Delcath Announces Ratio for Reverse Split Authorization

Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Company's Board of Directors has authorized a...

DCTH : 2.7500 (unch)
Delcath Announces Shareholder Approval of Consent Solicitation

Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that shareholders have approved the provisions of the...

DCTH : 2.7500 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade DCTH with:

Key Turning Points

2nd Resistance Point 2.8833
1st Resistance Point 2.8167
Last Price 2.7500
1st Support Level 2.6167
2nd Support Level 2.4833

See More

52-Week High 45,500.0000
Fibonacci 61.8% 28,119.4640
Fibonacci 50% 22,750.6090
Fibonacci 38.2% 17,381.7530
Last Price 2.7500
52-Week Low 1.2200

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar